Posted on Wed 10 Jun 2020, 12:04 PM

Singapore has approved the use of the anti-viral drug remdesivir to treat seriously ill coronavirus patients, authorities said Wednesday, becoming the latest country to do so.

The US authorised the emergency use of remdesivir in hospitals at the start of May, followed by Japan and South Korea, while Europe has been considering following suit.

It has been granted conditional approval in Singapore for treatment of some adult virus patients, such as those who require intensive breathing support, the country’s health products regulator said.

The regulator, the Health Sciences Authority, said it had “expedited the review of remdesivir given the urgent public health need during the COVID-19 pandemic”.

As a condition for the approval, the authority requires US-based Gilead Sciences, which developed the drug, to collect safety data and monitor its use.

Singapore initially kept the virus in check with a strict regime of testing and contact tracing, only for serious outbreaks to emerge later in dormitories housing low-paid foreign workers.

The city-state now has the highest recorded number of infections in Southeast Asia with nearly 39,000 cases, mostly among foreign workers. The death toll stands at 25.

AFP

 

Add new comment

Filtered HTML

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
By submitting this form, you accept the Mollom privacy policy.
Get the Latest News updates from Homeland New. Read more
Phone: +234 818 217 4858
Email: info@homelandnewsng.com

Newsletter

Subscribe to our Newsletter to get latest updates!

Connect With Us